Drug Profile
Hepatitis B vaccine - Provalis
Latest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator Provalis
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 27 May 1998 Discontinued-Preclinical for Hepatitis B in United Kingdom (PO)
- 17 Apr 1996 New profile
- 17 Apr 1996 Preclinical development for Hepatitis B in United Kingdom (PO)